Gene · 2946
Papers3,915
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,915
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated strategy of RNA-sequencing and network pharmacology for exploring the protective mechanism of Shen-Shi-Jiang-Zhuo formula in rat with non-alcoholic fatty liver disease. | Pharm Biol | 2022 | 36124995 | PubTator, text mining | PubMed |
| PRDX6: A protein bridging S-palmitoylation and diabetic neuropathy. | Front Endocrinol (Lausanne) | 2022 | 36120430 | PubTator, text mining | PubMed |
| An updated analysis on the association of GSTM1 polymorphism and smoking exposure with the increased risk of coronary heart disease. | J Int Med Res | 2022 | 36112810 | PubTator, text mining | PubMed |
| Genetic profiles to identify talents in elite endurance athletes and professional football players. | PLoS One | 2022 | 36112609 | PubTator, text mining | PubMed |
| Neuroprotective potential of Cannabis sativa-based oils in Caenorhabditis elegans. | Sci Rep | 2022 | 36100636 | PubTator, text mining | PubMed |
| Reversal of High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease by Metformin Combined with PGG, an Inducer of Glycine N-Methyltransferase. | Int J Mol Sci | 2022 | 36077467 | PubTator, text mining | PubMed |
| The Role of Extracellular Vesicles in Senescence. | Mol Cells | 2022 | 36058888 | PubTator, text mining | PubMed |
| GSTM2 is a key molecular determinant of resistance to SG-ARIs. | Oncogene | 2022 | 36038661 | PubTator, text mining | PubMed |
| Genomic Pattern of GSTM1 and T1 Gene Null polymorphism of Head and Neck Cancer Patients in Eastern India. | Asian Pac J Cancer Prev | 2022 | 36037119 | PubTator, text mining | PubMed |
| Utilization of hypoxia-derived gene signatures to predict clinical outcomes and immune checkpoint blockade therapy responses in prostate cancer. | Front Genet | 2022 | 36035150 | PubTator, text mining | PubMed |
| Do Polymorphisms of the TERT, GSTM1, and GSTT1 Genes Increase Laryngeal Cancer Susceptibility in Smokers of Romanian Descent? | Medicina (Kaunas) | 2022 | 36013573 | PubTator, text mining | PubMed |
| Endothelial Cell Dysfunction and Nonalcoholic Fatty Liver Disease (NAFLD): A Concise Review. | Cells | 2022 | 36010588 | PubTator, text mining | PubMed |
| Uptake and Immunomodulatory Properties of Betanin, Vulgaxanthin I and Indicaxanthin towards Caco-2 Intestinal Cells. | Antioxidants (Basel) | 2022 | 36009345 | PubTator, text mining | PubMed |
| The Leucocyte Telomere Length, GSTM1 and GSTT1 Null Genotypes and the Risk of Chronic Obstructive Pulmonary Disease. | Curr Issues Mol Biol | 2022 | 36005153 | PubTator, text mining | PubMed |
| Cruciferous vegetables as a treasure of functional foods bioactive compounds: Targeting p53 family in gastrointestinal tract and associated cancers. | Front Nutr | 2022 | 35990357 | PubTator, text mining | PubMed |
Development of a screening protocol to identify persons who are responsive to wood smoke particle-induced airway inflammation with pilot assessment of GSTM1 genotype and asthma status as response modifiers. | Inhal Toxicol | 2022 | 35968917 | PubTator, text mining | PubMed |
| Comprehensive analysis of the glutathione S-transferase Mu (GSTM) gene family in ovarian cancer identifies prognostic and expression significance. | Front Oncol | 2022 | 35965498 | PubTator, text mining | PubMed |
| Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH). | Signal Transduct Target Ther | 2022 | 35963848 | PubTator, text mining | PubMed |
| Differential proteomic analysis of mouse cerebrums with high-fat diet (HFD)-induced hyperlipidemia. | PeerJ | 2022 | 35942128 | PubTator, text mining | PubMed |
| Immunometabolism characteristics and a potential prognostic risk model associated with TP53 mutations in breast cancer. | Front Immunol | 2022 | 35935965 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2946/papers?page=12